US Patent Office Plans Review In Boston-Edwards TAVR Battle

The US Patent & Trademark Office has found three grounds on which to review four claims in a Boston Scientific TAVR patent being challenged by Edwards Lifesciences. The companies have seen mixed recent verdicts in European bodies on related patent disputes.